IP Library Granted Patent US 7,763,475
Granted Patent B2
US 7,763,475 · App. 11/706,654 · Granted Jul 27, 2010

Measurement and use of molecular interactions

Assignee: Inverness Medical Switzerland GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,763,475
App. No.
11/706,654
Granted
Jul 27, 2010
Kind
B2
Abstract

The present invention is based on the realization that the bonds between a target molecule, or a target molecule attached to a particle, and a surface, can be ruptured by mechanically oscillating the surface at increasing amplitude, leading to detachment of the target molecule or particle from the surface. The required acceleration, and hence force, will depend on a variety of factors, including the mass of the molecule or particle, the nature of the bond to the surface and the geometric shape or size of the target molecule or particle. The present invention may therefore be used to separate or to size different target molecules, or to detect their presence.

Claims (25)

1. A method for separating first and second components in a fluid, which comprises the steps of:

i. contacting the fluid with a surface having attached thereto a binding reagent to which said first and second components may bind; and

ii. oscillating the surface at a first amplitude sufficient to rupture the bond between the binding reagent and the first component, but insufficient to rupture the bond between the binding reagent and the second component, thereby reducing or preventing the binding of the first component but not the second component

wherein said first and second components are sufficiently different with respect to mass, size, nature of bond to the binding reagent, and/or geometric shape, to permit separation by said oscillation method.

2. The method according to claim 1 , wherein the first component is more weakly bound to the binding reagent than the second component.

3. The method according to claim 1 , wherein the first component has a lower effective mass than the second component.

4. The method according to claim 1 , wherein the first component has a lower mass (molecular weight) than the second component.

5. The method according to claim 1 , wherein the first component has a smaller size than the second component.

6. The method according to claim 1 , wherein the first component has a different shape to the second component.

7. The method according to claim 1 , wherein the second component is an aggregate of the first component.

8. The method according to claim 1 , wherein the second component is an oligomer comprising the first component.

9. The method according to claim 1 , wherein the or each component is a protein, antibody, antigen, enzyme, enzyme inhibitor or polynucleotide.

10. The method according to claim 1 , wherein the or each component is a cell, bacterium, virus, prion or phage.

11. The method according to claim 1 , wherein the second component is an oligomer of non-disease forming proteins.

12. The method according to claim 1 , wherein the second component is an aggregate of disease-forming proteins.

13. The method according to claim 1 , wherein the first component is a protein and the second component is a prion comprising said protein.

14. The method according to claim 1 , wherein at least one component is immobilized to a microsphere.

15. The method according to claim 1 , wherein the surface comprises a ligand which binds selectively to one component.

16. The method according to claim 1 , wherein the oscillating is in the plane of the surface.

17. The method according to claim 1 , which additionally comprises:

iii. oscillating the surface at the second increased amplitude, sufficient to rupture the bond between the binding reagent and the second component, thereby releasing the second component.

18. The method according to claim 17 , wherein the fluid comprises a third component that can bind to the surface, and the method optionally also comprises:

iv. oscillating the surface at a third amplitude sufficient to rupture also the bond between the binding reagent and the third component.

19. The method according to claim 1 wherein the surface is formed on a transducer which comprises a piezoelectric material.

20. The method according to claim 1 wherein the amplitude of the oscillation of the surface is increased, whilst the frequency of the oscillations is held constant or approximately constant.

Assignments (3)
CONFIRMATORY ASSIGNMENT Recorded Oct 30, 2020
From: ALERE SWITZERLAND GMBH
To: ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY
Reel/Frame 054260/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2008
From: AKUBIO LIMITED
To: INVERNESS MEDICAL SWITZERLAND GMBH
Reel/Frame 020791/0421 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2007
From: KLENERMAN, DAVID; OSTANIN, VICTOR PETROVICH; DULTSEV, FEDOR NIKOLAIEVICH; COOPER, MATTHEW
To: AKUBIO LTD.
Reel/Frame 019465/0208 →
Priority Claims (2)
GB 9909308.0 · Apr 22, 1999 · national
GB 0603392.2 · Feb 21, 2006 · national
Continuity (3)
Continuation In Part 1035089200 · Jan 24, 2003
Continuation 0970048500
Related Publication 20070218534A1 · Sep 20, 2007